Sysco Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 13 out of 29 in the Food & Drug Retailing industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 87.81.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Media Coverage
The current financial score of Sysco Corp is 5.42, ranking 26 out of 29 in the Food & Drug Retailing industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 20.52B, representing a year-over-year increase of 4.70%, while its net profit experienced a year-over-year increase of 15.21%.
The current valuation score of Sysco Corp is 6.04, ranking 23 out of 29 in the Food & Drug Retailing industry. Its current P/E ratio is 20.04, which is 44.15% below the recent high of 28.88 and 14.32% above the recent low of 17.17.

The current earnings forecast score of Sysco Corp is 7.47, ranking 14 out of 29 in the Food & Drug Retailing industry. The average price target is 88.00, with a high of 98.00 and a low of 81.00.


Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Sysco Corp is 6.67, ranking 22 out of 29 in the Food & Drug Retailing industry. Currently, the stock price is trading between the resistance level at 75.79 and the support level at 70.32, making it suitable for range-bound swing trading.

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Sysco Corp is 10.00, ranking 1 out of 29 in the Food & Drug Retailing industry. The latest institutional shareholding proportion is 90.46%, representing a quarter-over-quarter increase of 0.54%. The largest institutional shareholder is The Vanguard, holding a total of 60.12M shares, representing 12.57% of shares outstanding, with 0.50% decrease in holdings.

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Drug Retailing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Sysco Corp is 9.77, ranking 1 out of 29 in the Food & Drug Retailing industry. The company's beta value is 0.66. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.